Companies: 10,795·Total market cap: $144.5T
Anteris Technologies Global Corp.

Anteris Technologies Global Corp.

AVRNASDAQHealthcare● Active
$9.34
$-0.30(-3.11%)
Market Cap$343604226
P/E Ratio—
52W High$10.14
52W Low$2.85
PE RatioMarket CapForecast

Anteris Technologies Global Corp. (AVR) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

avr · pe ratio · data through Dec 31, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Anteris Technologies Global Corp. (AVR) measures how much investors pay for each dollar of the company's trailing earnings. AVR's current PE ratio of N/A is calculated by dividing its stock price of $9.34 by its TTM earnings per share of -$4.04.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31

Forward P/E
N/A
FY2027 est. EPS $-1.12
Based on 1 analyst
EPS (TTM)
-$4.04
TTM · diluted EPS
PEG Ratio
0.07
Below 1.0 · Growth adjusted
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Anteris Technologies Global Corp. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-08

PE Ratio History

2020 – 2025 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Medical - Devices · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Anteris Technologies Global Corp.
Anteris Technologies Global Corp.You
AVR
$344MN/A—-$4.04
Anika Therapeutics, Inc.
Anika Therapeutics, Inc.
ANIK
$194MN/A—-$0.76
Accuray Incorporated
Accuray Incorporated
ARAY
$42MN/A—-$0.02
Atlantic International Corp.
Atlantic International Corp.
ATLN
$61MN/A—-$1.08
Cybin Inc.
Cybin Inc.
CYBN
$413MN/A—-$0.61
LENSAR, Inc.
LENSAR, Inc.
LNSR
$68MN/A—-$2.87
Lucid Diagnostics Inc.
Lucid Diagnostics Inc.
LUCD
$98MN/A—-$0.57

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 6 of 6 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2025-12-31Latest
FY2025
—$-3.99—
2024-12-31
FY2024
—$-3.77—
2023-12-31
FY2023
—$-1.28—
2022-12-31
FY2022
—$-0.85—
2021-12-31
FY2021
—$-0.48—
2020-12-31
FY2020
—$-0.33—

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Anteris Technologies Global Corp. (AVR) measures how much investors pay for each dollar of the company's trailing earnings. AVR's current PE ratio of N/A is calculated by dividing its stock price of $9.34 by its TTM earnings per share of -$4.04.

PE Ratio = Stock Price ÷ EPS (TTM)
= $9.34 ÷ -$4.04 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.
Price historyFinancial statementsEarnings

Frequently asked questions

AVR pe ratio · 6 questions

AVR's current PE ratio is N/A as of 2026-06-08, based on a stock price of $9.34 and TTM EPS of -$4.04. Data sourced from Financial Modeling Prep via AVR's SEC 10-K and 10-Q filings.

AVR PE ratioWhat is AVR PE ratioCurrent PE ratio of AVRAVR PE ratio today

▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Anteris Technologies Global Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08